HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

670.135

+9.6471.46%

Number of Gainers:17

Number of Losers:13

Number of Flat:4

PE:- -

High:678.126

Open:660.587

Low:657.123

Close:660.489

Volume:153.72M

Turnover:4.63B

Market Cap:429.95B

Float Cap:380.25B

Loading ...

Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen

Biocytogen-B Shares Extend Rally with Over 6% Gain on AI-Driven Obesity Drug Partnership

Biopharma Stocks Surge with Multiple Limit-Ups, Industry Giant Reports Nearly 20 Billion Yuan Net Profit

RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial

MT Newswires Live

Revised title

Trump's Pharmaceutical Tariff Deadline Approaches: Firms Without Pricing Agreements Face 100% Levies

Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment

Hong Kong Stock Announcement Highlights | Biocytogen-B and Sihuan Pharmaceutical Form Strategic Partnership to Accelerate Innovative Drug Development in Weight Loss and Other Areas

Pharmaceutical Sector Returns to the Spotlight

EDDING GENOR (06998) Allocates HK$36,500 for Share Buyback on April 1

Ascentage Pharma relocates Hong Kong principal office to Central district

BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy

HBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives

Simply Wall St.

April Trading Commences with Gains as Key Indices Close Higher, Led by Tech and Healthcare Sectors

Hing Yip Holdings Calls Off Acquisition of 51% Stake in Guangzhou Institute of Respiratory Medicine Pharmaceutical Technology

Zai Lab, Amgen partner on global trial of DLL3 ADC with Imdelltra in SCLC

Zai Lab Ltd - Announces Global Clinical Trial Collaboration With Amgen for Es-Sclc

THOMSON REUTERS

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Dll3 ADC, Zocilurtatug Pelitecan, in Combination With a Bispecific T-Cell Engager Therapy

THOMSON REUTERS

HEARTCARE-B Achieves First Annual Profit, Signaling Performance Turnaround and Valuation Rebound

Baiyunshan Pharmaceutical Division Secures NMPA Approval for Calcitriol Soft Capsules

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1574/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":670.1354,"timestamp":1775117299351,"preClose":660.4887,"halted":0,"volume":153717417,"delay":0,"changeRate":0.014605,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed The day following Ching Ming Festival","change":9.646667,"latestTime":"04-02 16:00:00","open":660.58655,"high":678.1257,"low":657.12256,"amount":4633342498,"amplitude":0.031799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"pbRate":5.274197,"peRate":-86.845688,"turnoverRate":0.005552,"increases":17,"decrements":14,"flats":2,"marketCap":429946652416,"floatMarketCap":380251567184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":678.1257,"amplitude":0.031799,"preClose":660.4887,"low":657.12256,"pbRate":"5.274197","latestPrice":670.1354,"volume":153717417,"delay":0,"open":660.58655,"prevYearClose":556.26263,"prevWeekClose":670.135,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":579.36,"twentyDayClose":522.155,"sixtyDayClose":580.971,"secType":"PLATE","market":"HK","turnoverRate":0.005552,"peRate":-86.845688,"marketCap":429946652416,"floatMarketCap":380251567184,"timestamp":1775117299351,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":17,"down":13,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158231510","title":"Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen","url":"https://stock-news.laohu8.com/highlight/detail?id=1158231510","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158231510?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:40","pubTimestamp":1775101249,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) saw an increase of over 4% in morning trading. At the time of writing, the stock was up 4.82%, trading at HK$15.88 with a turnover of HK$288 million. On April 1, Zai Lab announced a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00B4R5TH58.HKD","LU2488822045.USD","BK4588","ZLAB","LU1571399168.USD","LU0122379950.USD","LU0889565916.HKD","IE0009355771.USD","LU1057294990.SGD","BK4581","BK1161","LU1023059063.AUD","LU2468319806.SGD","LU0320765992.SGD","LU2242652126.USD","BK4533","BK4526","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4566","LU1983299246.USD","LU2089984988.USD","09688","BK1588","LU0058720904.USD","BK4531","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK1574","IE0002141913.USD","SG9999001440.SGD","BK4139","AMGN","LU0868494617.USD","LU1061106388.HKD","LU2242646821.SGD","LU0289739699.SGD","BK4599","BK4585","BK4534","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141444588","title":"Biocytogen-B Shares Extend Rally with Over 6% Gain on AI-Driven Obesity Drug Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1141444588","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141444588?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:36","pubTimestamp":1775100980,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) rose more than 6% again, reaching HK$63.3 at the time of writing, with a trading volume of HK$56.0117 million. The increase follows the announcement of a formal strategic...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","VXUS","159992","02315","BK1574","BK1600","00460","AGIX","688796","BK1161","06978","BK4588","BK0216","CHAT","BK4585","AIPO","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138030919","title":"Biopharma Stocks Surge with Multiple Limit-Ups, Industry Giant Reports Nearly 20 Billion Yuan Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1138030919","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138030919?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:23","pubTimestamp":1775100203,"startTime":"0","endTime":"0","summary":"The A-share biopharmaceutical sector showed strong momentum during the early trading session on April 2. By approximately 10:35 AM, Tianjin Pharmaceutical Group surged by the 5% daily limit for the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624352170","title":"RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2624352170","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624352170?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:14","pubTimestamp":1775099668,"startTime":"0","endTime":"0","summary":"RemeGen  secured Chinese regulatory approval to begin clinical trials of RC288, according to a Hong Kong bourse filing Wednesday.Shares of the biopharmaceutical firm gained nearly 4% in morning trade Thursday.The company plans to conduct a Phase I/IIa clinical trial of the drug as a treatment for solid tumors.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09995","LU1969619763.USD","BK1574","BK1161","LU2328871848.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142270681","title":"Revised title","url":"https://stock-news.laohu8.com/highlight/detail?id=1142270681","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142270681?lang=en_us&edition=fundamental","pubTime":"2026-04-02 10:44","pubTimestamp":1775097877,"startTime":"0","endTime":"0","summary":"CICC Maintains Outperform Rating on OCUMENSION-B (01477) with HK$10.16 Target Price","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","EWH","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143121025","title":"Trump's Pharmaceutical Tariff Deadline Approaches: Firms Without Pricing Agreements Face 100% Levies","url":"https://stock-news.laohu8.com/highlight/detail?id=1143121025","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143121025?lang=en_us&edition=fundamental","pubTime":"2026-04-02 10:24","pubTimestamp":1775096674,"startTime":"0","endTime":"0","summary":"According to media reports citing informed sources, the Trump administration is expected to announce as early as Thursday local time that it will impose massive tariffs on pharmaceutical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108555307","title":"Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1108555307","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108555307?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:52","pubTimestamp":1775094739,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) rose more than 4% in Hong Kong trading, with the stock up 4.22% to HK$15.79 by the time of writing, as turnover reached HK$98.01 million. The increase follows an announcement on April...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","BK4534","BK4581","AMGN","IE0002141913.USD","BK4139","BK4585","LU2089984988.USD","IE00B2B36J28.USD","BK1588","BK4533","BK4526","09688","LU0320765992.SGD","LU1023059063.AUD","LU1057294990.SGD","IE0009355771.USD","BK4588","LU0889565916.HKD","LU2112291526.USD","LU2468319806.SGD","LU1983299246.USD","BK4548","ZLAB","LU1061106388.HKD","LU2488822045.USD","BK1161","IE00BJJMRZ35.SGD","BK4531","LU0122379950.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","VXUS","LU0109394709.USD","BK4599","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0868494617.USD","BK1574","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158222835","title":"Hong Kong Stock Announcement Highlights | Biocytogen-B and Sihuan Pharmaceutical Form Strategic Partnership to Accelerate Innovative Drug Development in Weight Loss and Other Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=1158222835","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158222835?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:21","pubTimestamp":1775092887,"startTime":"0","endTime":"0","summary":"Major Developments: Biocytogen-B (02315) and Sihuan Pharmaceutical (00460) have entered into a strategic collaboration to accelerate the research and development of innovative drugs in multiple...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU1880383366.USD","LU2506951792.HKD","LU2778985437.USD","LU0314109678.HKD","LU0828238088.HKD","SG9999015945.SGD","LU0561508036.HKD","LU1242518857.USD","LU0588545730.USD","LU2039709279.SGD","02315","LU0326950275.SGD","LU0979878070.USD","SG9999006597.SGD","LU0054450605.USD","LU0463099449.HKD","BK1119","LU0214875030.USD","LU0708995583.HKD","BK1124","LU1861219969.SGD","BK1240","LU2357125470.USD","LU0509642566.USD","LU0143863784.USD","LU2097828714.EUR","BK1522","LU0449509016.USD","LU0165289439.USD","BK1574","BK1191","IE00B0JY6N72.USD","81211","SG9999015986.USD","LU1282651048.USD","LU2249611893.SGD","LU0043850808.USD","LU0229945570.USD","SG9999001226.SGD","LU0084288322.USD","LU1868838027.USD","LU0516422952.EUR","LU0594300419.USD","LU0211977185.USD","BK4585","LU0293314216.USD","LU0359201885.HKD","LU0315179316.USD","BYDDY","IE00BZ08YT58.USD","LU0289960550.SGD","LU0593848301.USD","LU1861214812.USD","BK1600","LU1224444064.USD","SG9999006514.SGD","LU0289739343.SGD","BK1540","LU0289961442.SGD","LU0269904917.USD","LU0469268626.HKD","00460","BK1582","LU1282651121.HKD","LU0348825331.USD","LU0516423091.SGD","LU2476274308.USD","BK1509","BK1161","LU1868837722.USD","688796","BK1521","BK1594","LU0359201612.USD","SG9999002828.SGD","IE00BZ08YR35.GBP","LU1719994722.HKD","SG9999015978.USD","LU0348805143.USD","LU0588545904.SGD","LU1328277881.USD","LU0511384066.AUD","LU2476274720.SGD","LU0143863198.USD","BK1610","LU0039217434.USD","LU1880383440.USD","LU0449515922.USD","LU0348827113.USD","HYDD.SI","LU0359202008.SGD","LU0417516902.SGD","SG9999015952.SGD","LU0865486749.SGD","LU0516422440.USD","SG9999002463.SGD","LU0315178854.USD","LU1720050803.USD","LU0819123356.HKD","LU1251922891.USD","LU1303224171.USD","LU0588546209.SGD","LU2360107325.USD","LU0327786744.USD","LU0871576103.HKD","LU0531971595.HKD","LU2097828631.EUR","002594","LU0823426480.USD","BK1589","LU0540923850.HKD","LU0516422366.SGD","LU2097828557.USD","LU2449936058.SGD","BK1593","EVS.SI","LU1808992512.USD","LU0588545490.SGD","SG9999014674.SGD","LU0244354667.USD","80175","LU1242518931.SGD","LU2097828805.USD","LU0823426308.USD","LU0175139822.USD","LU1961090484.USD","LU0594300179.USD","LU1770034418.SGD","BK1515","IE00BZ08YS42.EUR","LU0819121731.USD","LU0516423174.USD","LU0856984785.SGD","LU0531970944.HKD","LU0254981946.USD","BK4588","LU0605514214.HKD","LU0505663152.USD","LU2399975544.HKD","LU1868837565.USD","LU0634319403.HKD","LU0348735423.USD","LU0307460666.USD","LU0823414478.USD","LU0164865239.USD","LU1188198961.HKD","LU0823039010.USD","LU2153592121.USD","LU0052750758.USD","LU0572944931.SGD","LU0259732245.USD","LU2348774022.SGD","LU0823038988.USD","LU1813983027.USD","BK1539","IE00BD6J9T35.USD","LU1023057109.AUD","BK0216","GELYY","LU0823414551.USD","LU0543330566.HKD","LU2294711713.HKD","LU0650527681.SGD","LU1794554557.SGD","LU2097828474.EUR","LU0164872284.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193402469","title":"Pharmaceutical Sector Returns to the Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=1193402469","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193402469?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:12","pubTimestamp":1775092340,"startTime":"0","endTime":"0","summary":"The recent period of intensive financial report disclosures has brought many topics worth discussing. Due to the need for extensive reading of financial reports and participation in earnings calls,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167806618","title":"EDDING GENOR (06998) Allocates HK$36,500 for Share Buyback on April 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1167806618","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167806618?lang=en_us&edition=fundamental","pubTime":"2026-04-02 06:14","pubTimestamp":1775081651,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on April 1, 2026, the company repurchased 13,500 of its own shares at a total cost of HK$36,500.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624514568","title":"Ascentage Pharma relocates Hong Kong principal office to Central district","url":"https://stock-news.laohu8.com/highlight/detail?id=2624514568","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624514568?lang=en_us&edition=fundamental","pubTime":"2026-04-01 22:16","pubTimestamp":1775052975,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International relocated principal place of business in Hong Kong effective April 1, 2026.New address: Unit 906, 9/F, Haleson Building, 1 Jubilee Street, Central, Hong Kong.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6Q4VBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624165515","title":"BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2624165515","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624165515?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:34","pubTimestamp":1775046889,"startTime":"0","endTime":"0","summary":"BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager TherapyZai Lab Ltd ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAQW7D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","09688","LU2242652126.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0122379950.USD","BK1574","BK4534","IE00BJT1NW94.SGD","BK4533","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","AMGN","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1571399168.USD","BK4139","LU2112291526.USD","BK4588","LU1023059063.AUD","BK4581","LU1983299246.USD","BK4585","LU1061106388.HKD","LU2089984988.USD","BK1588","LU0058720904.USD","LU2488822045.USD","IE00B2B36J28.USD","LU0289739699.SGD","BK1161","LU2242646821.SGD","BK4599","BK4566","IE0009355771.USD","SG9999001440.SGD","LU1057294990.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624196865","title":"HBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2624196865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624196865?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:26","pubTimestamp":1775046404,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings growth over the last 12 months. The company has seen revenue move from US$23.7 million and US$14.4 million in the first and second halves of FY 2024 to US$101.3 million in the first half of FY 2025, while basic EPS shifted from roughly US$0.002 in each FY 2024 half to just over US$0.09, setting up...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02142","BK1574","HBM","BK1583","BK4168","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154371411","title":"April Trading Commences with Gains as Key Indices Close Higher, Led by Tech and Healthcare Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1154371411","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154371411?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:20","pubTimestamp":1775046042,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, with several stocks showing strong upward momentum.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"206c95150b0ddd65d29e28386e88ca3f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1515","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194604777","title":"Hing Yip Holdings Calls Off Acquisition of 51% Stake in Guangzhou Institute of Respiratory Medicine Pharmaceutical Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1194604777","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194604777?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:08","pubTimestamp":1775045294,"startTime":"0","endTime":"0","summary":"Hing Yip Holdings (00132) has announced the termination of a planned acquisition by its subsidiary, Guangdong Zhongchuang Xingke Asset Management Co., Ltd. The subsidiary had intended to purchase a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00132","BK1161","BK1515","BK1574","159938","09939","BK1164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624259003","title":"Zai Lab, Amgen partner on global trial of DLL3 ADC with Imdelltra in SCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2624259003","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624259003?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:31","pubTimestamp":1775043072,"startTime":"0","endTime":"0","summary":"Zai Lab entered global clinical trial collaboration with Amgen to test DLL3-targeting ADC zocilurtatug pelitecan with Amgen’s IMDELLTRA in extensive-stage small cell lung cancer.Amgen will sponsor and run global Phase 1b study evaluating safety, efficacy of combination.Zai Lab will retain full ownership of zocilurtatug pelitecan.Agreement includes supply arrangement under which Zai Lab will provide study drug to Amgen.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL4kTWhs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","IE0002141913.USD","IE00B4R5TH58.HKD","BK4139","AMGN","BK4585","LU0122379950.USD","LU0058720904.USD","BK4599","LU0868494617.USD","SG9999001440.SGD","BK4581","LU2112291526.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","09688","LU1571399168.USD","LU2468319806.SGD","LU0109394709.USD","BK4533","LU1023059063.AUD","BK1574","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4534","IE00B2B36J28.USD","LU0289739699.SGD","LU2242646821.SGD","BK4566","IE0009355771.USD","BK1161","LU0889565916.HKD","BK4588","LU0320765992.SGD","LU2089984988.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624716590","title":"Zai Lab Ltd - Announces Global Clinical Trial Collaboration With Amgen for Es-Sclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2624716590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624716590?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAQW7D2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU1983299246.USD","BK4139","LU0868494617.USD","IE00B2B36J28.USD","LU2089984988.USD","LU2112291526.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4581","LU0109394709.USD","BK4533","LU0889565916.HKD","LU1061106388.HKD","LU2488822045.USD","LU0058720904.USD","BK4599","BK4588","SG9999001440.SGD","AMGN","LU0289739699.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2242652126.USD","IE0002141913.USD","BK4566","LU0122379950.USD","BK1161","BK4534","09688","LU0320765992.SGD","LU1023059063.AUD","LU2242646821.SGD","BK1574","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4585","LU1571399168.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624246590","title":"Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Dll3 ADC, Zocilurtatug Pelitecan, in Combination With a Bispecific T-Cell Engager Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2624246590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624246590?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAQW7D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1574","BK1161","09688","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143432467","title":"HEARTCARE-B Achieves First Annual Profit, Signaling Performance Turnaround and Valuation Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1143432467","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143432467?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:11","pubTimestamp":1775041890,"startTime":"0","endTime":"0","summary":"HEARTCARE-B (06609) has released its annual results for 2025. The financial report shows that the company generated revenue of 408 million yuan during the period, a year-on-year increase of 46.9%. At...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1587","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132620883","title":"Baiyunshan Pharmaceutical Division Secures NMPA Approval for Calcitriol Soft Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=1132620883","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132620883?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:52","pubTimestamp":1775040744,"startTime":"0","endTime":"0","summary":"Baiyunshan (00874) announced that its subsidiary, Baiyunshan Pharmaceutical General Factory, recently received a Drug Supplement Application Approval Notice for Calcitriol Soft Capsules from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0183","BK0188","BK1515","BK0070","BK1197","BK0239","BK1606","BK0175","BK0028","00874","BK0196","600332","BK0096","BK1521","BK1191","BK1574","BK0097","01477"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":3,"totalSize":360,"code":"91000000","status":"200"}]}}